Resultats de la cerca - James Markowitz
- Mostrar 1 - 20 resultats de 46
- Anar a la pàgina següent
-
1
-
2
Growth Failure in Pediatric Inflammatory Bowel Disease per James Markowitz, Kathy Grancher, Joanne Rosa, Harvey Aiges, Fredric Daum
Publicat 1993Artigo -
3
-
4
-
5
Transition of the Patient With Inflammatory Bowel Disease From Pediatric to Adult Care: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and... per Robert N. Baldassano, George D. Ferry, Anne Griffiths, David R. Mack, James Markowitz, Harland S. Winter
Publicat 2002Artigo -
6
-
7
Corticosteroid Therapy in the Age of Infliximab: Acute and 1-Year Outcomes in Newly Diagnosed Children With Crohn’s Disease per James Markowitz, Jeffrey S. Hyams, David Mack, Neal S. LeLeiko, Jonathan Evans, Subra Kugathasan, Marian Pfefferkorn, Adam Mezoff, Joel R. Rosh, Vasundhara Tolia
Publicat 2006Artigo -
8
-
9
Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis per Eytan Wine, David R. Mack, Jeffrey S. Hyams, Anthony Otley, James Markowitz, Wallace Crandall, Neal S. LeLeiko, Aleixo M. Muise, Anne M. Griffiths, Dan Turner
Publicat 2013Artigo -
10
C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis per Dan Turner, David Mack, Jeffrey S. Hyams, Neal S. LeLeiko, Anthony Otley, James Markowitz, Yair Kasirer, Aleixo M. Muise, Cynthia H. Seow, Mark S. Silverberg, Wallace Crandall, Anne M. Griffiths
Publicat 2011Artigo -
11
Pediatric modification of the Montreal classification for inflammatory bowel disease per Arie Levine, Anne M. Griffiths, James Markowitz, David C. Wilson, Dan Turner, Richard K. Russell, John Fell, Frank M. Ruemmele, Thomas D. Walters, Mary Sherlock, Marla Dubinsky, Jeffrey S. Hyams
Publicat 2010Artigo -
12
Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the <scp>VedoKids</scp> Prospective Multicentre Study per Ronen Stein, Dan Turner, Séamus Hussey, Aysha Kawasmi, Oren Ledder, Jeremiah Levine, James Markowitz, Manar Matar, E Orlanski-Meyer, Richard K. Russell, Ron Shaoul, Anat Yerushalmy‐Feler, Diane R. Mould, Máire Conrad
Publicat 2025Artigo -
13
Infliximab Therapy in Children With Concurrent Perianal Crohn Disease: Observations From REACH per Wallace Crandall, Jeffrey S. Hyams, Subra Kugathasan, Anne M. Griffiths, Julie Zrubek, Allan Olson, Grace Liu, Robert Heuschkel, James Markowitz, Stanley A. Cohen, Harland S. Winter, G. Veereman‐Wauters, George D. Ferry, Robert N. Baldassano
Publicat 2009Artigo -
14
Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children per Jeffrey S. Hyams, Anne M. Griffiths, James Markowitz, Robert N. Baldassano, William A. Faubion, Richard B. Colletti, Marla Dubinsky, Jarosław Kierkuś, Joel R. Rosh, Yaqin Wang, Bidan Huang, Barry Bittle, Michael Marshall, Andreas Lazar
Publicat 2012Artigo -
15
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children per Jeffrey S. Hyams, Wallace Crandall, Subra Kugathasan, Anne M. Griffiths, Allan Olson, Jewel Johanns, Grace Liu, Suzanne Travers, Robert Heuschkel, James Markowitz, Stanley A. Cohen, Harland S. Winter, G. Veereman‐Wauters, George D. Ferry, Robert N. Baldassano
Publicat 2006Artigo -
16
Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen per Sanam Soomro, Suresh Venkateswaran, Kamala Vanarsa, Marwa Kharboutli, Malavika Nidhi, Ramya Susarla, Ting Zhang, Prashanth Sasidharan, Kyung Hyun Lee, Joel R. Rosh, James Markowitz, Claudia Pedroza, Lee A. Denson, Jeffrey S. Hyams, Subra Kugathasan, Chandra Mohan
Publicat 2021Artigo -
17
Intercenter variation in initial management of children with Crohnʼs disease per Michael D. Kappelman, Athos Bousvaros, Jeffrey S. Hyams, James Markowitz, Marian Pfefferkorn, Subra Kugathasan, Joel R. Rosh, Anthony Otley, David Mack, Anne M. Griffiths, Jonathan Evans, Richard J. Grand, Christine R. Langton, Ken Kleinman, Jonathan A. Finkelstein
Publicat 2007Artigo -
18
Severe Pediatric Ulcerative Colitis: A Prospective Multicenter Study of Outcomes and Predictors of Response per Dan Turner, David R. Mack, Neal S. LeLeiko, Thomas D. Walters, Krista Uusoue, Steven T. Leach, Andrew S. Day, Wallace Crandall, Mark S. Silverberg, James Markowitz, Anthony Otley, David J. Keljo, Petar Mamula, Subra Kugathasan, Jeffrey S. Hyams, Anne M. Griffiths
Publicat 2010Artigo -
19
Long-term outcome of maintenance infliximab therapy in children with Crohnʼs disease per Jeffrey S. Hyams, Trudy Lerer, Anne M. Griffiths, Marian Pfefferkorn, Subra Kugathasan, Jonathan Evans, Anthony Otley, Ryan Carvalho, David Mack, Athos Bousvaros, Joel R. Rosh, Petar Mamula, Marsha Kay, Wallace Crandall, Maria Oliva‐Hemker, David J. Keljo, Neal S. LeLeiko, James Markowitz
Publicat 2008Artigo -
20
Growth Abnormalities Persist in Newly Diagnosed Children With Crohn Disease Despite Current Treatment Paradigms per Marian Pfefferkorn, Georgine Burke, Anne M. Griffiths, James Markowitz, Joel R. Rosh, David Mack, Anthony Otley, Subra Kugathasan, Jonathan Evans, Athos Bousvaros, M. Susan Moyer, Robert Wyllie, Maria Oliva‐Hemker, Ryan Carvalho, Wallace Crandall, David J. Keljo, TD Walters, Neal S. LeLeiko, Jeffrey S. Hyams
Publicat 2009Artigo
Eines de cerca:
Matèries relacionades
Medicine
Disease
Internal medicine
Inflammatory bowel disease
Crohn's disease
Gastroenterology
Ulcerative colitis
Immunology
Infliximab
Biology
Pediatrics
Cohort
Gene
Genetics
Confidence interval
Prospective cohort study
Surgery
Gene expression
Bioinformatics
Pathology
Cohort study
Colectomy
Corticosteroid
Inflammation
Microbiome
Pathogenesis
Pediatric gastroenterology
Chemotherapy
Computational biology
Crohn disease